机译:PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design
Berry Consultants LLC;
Dept Nucl Med,Univ Virginia;
F Hoffmann La Roche LtdMayo ClinBC Canc AgcyCharles Univ PragueFPO,Candiolo Canc InstDept Translat & Precis Med,Sapienza Univ RomaUniv Libraries,Texas A&M Univ;
Bayesian hierarchical model; clinical trial simulation; diffuse large B-cell lymphoma; end-of-treatment PET-complete response; meta-analysis; progression-free and overall survival; B-CELL LYMPHOMA; POSITRON-EMISSION-TOMOGRAPHY; INTERNATIONAL HARMONIZATION PROJECT; RESPONSE CRITERIA; PROGNOSTIC VALUE; FDG-PET; R-CHOP; NEOADJUVANT THERAPY; REMISSION STATUS; PREDICTIVE-VALUE;